Drugs / Allogeneic Human Mesenchymal Stem Cells (hMSCs)
Allogeneic Human Mesenchymal Stem Cells (hMSCs)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03487731 | Dec 2020 → Dec 2025 | — | Joshua M Hare | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic Human Mesenchymal Stem Cells (hMSCs) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03487731 ↗ |
| Modality | Cell therapy | “allogeneic human mesenchymal stem cells (hMSCs)” NCT03487731 ↗ |
| Route | Other | “delivered intra-facet” NCT03487731 ↗ |